Skip to main content
TipRanks
Go Ultimate75% OFF

Anthera Pharmaceuticals (ANTH) Financial Statements

238 Followers

Anthera Pharmaceuticals Financial Overview

Anthera Pharmaceuticals's market cap is currently $2.62K. The company's EPS TTM is $-0.47; its P/E ratio is 0.00; Anthera Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 17
Income Statement
Total Revenue$ 0.00
Gross Profit$ -281.00K
Operating Income$ -36.43M
EBITDA$ -26.59M
Net Income$ -16.93M
Balance Sheet
Cash & Short-Term Investments$ 2.20M
Total Assets$ 3.67M
Total Debt$ 0.00
Net Debt$ -2.20M
Total Liabilities$ 9.17M
Stockholders' Equity$ -5.50M
Cash Flow
Free Cash Flow$ -36.90M
Operating Cash Flow$ -36.90M
Investing Cash Flow$ 0.00
Financing Cash Flow$ 18.25M

Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

-18M-12M-6M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017RevenueEarningsProfit Margin

Anthera Pharmaceuticals Liabilities to Assets

04M8M12M248 %249 %250 %251 %LiabilitiesLiabilities to Assets2017AssetsLiabilitiesLiabilities to Assets

Anthera Pharmaceuticals Cash Flow

-40M-30M-20M-10M010M20M30M2017OperatingInvestingFinancing

Anthera Pharmaceuticals Forecast EPS vs Actual EPS

-4-3-2-101Q4 16Q1 17Q2 17Q3 17Q4 17EPS EstimateBeatMiss